Get the Stockscreener App
0.8998
5.34%
-0.0508
Profusa Inc stock is traded at $0.8998, with a volume of 80,174.
It is down -5.34% in the last 24 hours and down -55.23% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
See More
Previous Close:
$0.9506
Open:
$0.9221
24h Volume:
80,174
Relative Volume:
0.03
Market Cap:
$476.89K
Revenue:
$75,000
Net Income/Loss:
$-42.41M
P/E Ratio:
-0.005
EPS:
-179.8206
Net Cash Flow:
$-18.47M
1W Performance:
-6.54%
1M Performance:
-55.23%
6M Performance:
-55.23%
1Y Performance:
-97.79%
1-Day Range:
$0.8623
$0.9221
1-Week Range:
$0.8057
$0.9999
52-Week Range:
$0.0801
$51.90
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.8998 | 511.45K | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
111.25 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.21 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.27 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.83 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.60 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Stock (PFSA) Latest News
HRT Financial LP Trims Profusa Inc (PFSA) Stake in Recent 13DG Filing - GuruFocus
Profusa, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Profusa (PFSA) 10% owner HRT FINANCIAL reports net sale of 36,826 shares - Stock Titan
Profusa announces reverse stock split - Medical Buyer
Form 8K Profusa Inc For: 14 August By Investing.com - Investing.com Canada
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company - ADVFN
Enterprise value to EBIT forward of PROFUSA, INC. – OTC:NVACW - TradingView
Profusa announces 1-for-4 reverse stock split effective Aug. 17 - Investing.com
Profusa Announces 1-for-4 Reverse Stock Split Effective August 17, 2026 - quiverquant.com
Profusa Announces 1-for-4 Reverse Stock Split - marketscreener.com
Price to book forward of PROFUSA, INC. – OTC:NVACW - TradingView
Enterprise value to EBITDA forward of PROFUSA, INC. – OTC:NVACW - TradingView
HRT FINANCIAL LP (PFSA) reports August net share purchase in Profusa - Stock Titan
HRT Financial reports Profusa common share disposal worth $804.31 - Bitget
Profusa (PFSA) major holder HRT FINANCIAL LP reports August net share sales - Stock Titan
Profusa Ord Shs (PFSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HRT Financial LP Initiates Position in Profusa Inc (PFSA) Amid Deep Financial Distress - GuruFocus
Profusa, Inc. (PFSA) sees 10% owner HRT Financial purchase 15,924 shares - Stock Titan
Profusa (PFSA) investors disclose 9.99% blocked stake via notes and ELOC - Stock Titan
Profusa, Inc. (PFSA) major holder adds 9,874 common shares - Stock Titan
PFSA Insider Buying: 10% Owner Financial Hrt Purchases 1,310 Sha - GuruFocus
PFSA | Profusa, Inc. Common Stock Insider Trading - Quiver Quantitative
Profusa Announces Signing of Option Agreement for the - GlobeNewswire
Profusa Secures Option to Acquire G3 Vision Labs and Affiliates; Requires $30M Financing - TradingView
New Form 4 - Moomoo
HRT Financial discloses 82,561 Profusa (PFSA) common shares stake - Stock Titan
Profusa Inc. (PFSA) Declines 4.7% as Stock Tests Key Support LevelsFactor Valuation - dars.gov.et
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes - Yahoo Finance
Profusa signs term sheet to acquire diagnostics company By Investing.com - Investing.com South Africa
Why Is Profusa Stock Falling Monday? - Benzinga
Profusa Announces CEO Change and Plans to Acquire $111M Diagnostics Company in Major Growth Move 12 - Minichart
Profusa Announces Key Management Changes And Signing Of Non-Binding Term Sheet For The Acquisition Of A Commercial Stage Diagnostics Company - TradingView
Profusa: Ben Hwang Has Transitioned Into the Role of President of Profusa >PFSA - Moomoo
Profusa Plans Strategic Acquisition in Diagnostics Expansion - TipRanks
Profusa signs term sheet to acquire diagnostics company - Investing.com
Profusa (PFSA) pursues diagnostics acquisition and plans $7M convertible financing - Stock Titan
PFSA|Profusa Ord Shs|Price:0.892| - TradingKey
Profusa Announces Key Management Changes and Signing of - GlobeNewswire
Profusa, Inc. Revenue Breakdown – NASDAQ:PFSA - TradingView
Profusa Inc. (PFSA) Slips 2.84%: Testing Key Support at $1.62Size Factor - dars.gov.et
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Profusa Inc. (PFSA) Slides 2.84% as Stock Nears Key Support LevelRSI Overbought Alerts - dars.gov.et
Enterprise value to revenue forward of PROFUSA, INC. – OTC:NVACW - TradingView
Price to sales forward of PROFUSA, INC. – OTC:NVACW - TradingView
Price to earnings forward of PROFUSA, INC. – OTC:NVACW - TradingView
Profusa Inc. (PFSA) Drops Nearly 7% as Stock Tests Key Support LevelsBollinger Band - dars.gov.et
Strategy, Trump Media, Sequans, Blockchain Group, and Profusa scoop $2.9B BTC off the market - MSN
Profusa approves 1-for-25 reverse stock split; shares tumble - MSN
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year - Stocktwits
Profusa Stock Short Interest Rises to 44.46% - Quiver Quantitative
Profusa files resale prospectus for up to 7,170,891 shares - scanx.trade
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):